Fertility preservation and sperm donation in transgender individuals: The current situation within the French CECOS network.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Eustache Florence, Drouineaud Véronique, Mendes Nicolas, Delépine Béatrice, Dupont Charlotte, Mirallié Sophie, Papaxanthos Aline, Metzler-Guillemain Catherine, Rives-Feraille Aurélie, Magnan Fanny, Grèze Cécile, Hennebicq Sylviane, Koscinski Isabelle, Drapier Hortense, Frapsauce Cynthia, Mayeur Anne, Carlotti Marie-Ange, Mons Joffrey, Schmitt Françoise, May-Panloup Pascale, Blagosklonov Oxana, Brugnon Florence, Mestres Stéphanie, Cabry Rosalie, Fauque Patricia, Loup-Cabaniols Vanessa, Ravel Célia, Lévy Rachel, Patrat Catherine, Thibault Emmanuelle, Frydman Nelly, Bujan Louis, Morinière Catherine, Ducrocq Bérengère, Rives Nathalie
Аннотация
OBJECTIVES: To evaluate the distribution of care on the French territory concerning fertility preservation and sperm donation in transgender individuals.
MATERIALS AND METHODS: A multicentric national survey was carried out between January 2019 and October 2020 in 28 assisted reproductive technology centres of the French CECOS (Centres d'Etudes et de Conservation des Oeufs et du Sperme) network. Each centre was questioned to find out how many transgender individuals came, were informed and cared for fertility preservation and sperm donation.
RESULTS: Concerning fertility preservation, 71.4% of centres received transgender individuals and performed gamete cryopreservation; 581 transgender individuals consulted for fertility preservation. Transgender women were more likely to desire (p < 0.0001) and achieve (p < 0.0001) fertility preservation than transgender men. Concerning sperm donation in couples including a transgender man, 68% of centres offer the complete course from the first consultation to the completion of the assisted reproductive technology cycles; 122 offsprings have been conceived with sperm donation in couples including a transgender man since 1999.
DISCUSSION: Our results showed that even if all centres do not propose fertility preservation or sperm donation in transgender individuals, these assisted reproductive technologies are present throughout the French territory. The major point is that both fertility preservation and sperm donation in transgender individuals have grown significantly and that the care of these patients is improving year after year.
CONCLUSION: In France, most of CECOS centres can take care of transgender individuals for fertility preservation and sperm donation. The French Bioethics Law allows these latter, and transgender individuals can benefit from a financial support of the national health care insurance for fertility preservation and sperm donation.